Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2007
10/25/2007WO2007119279A1 Dna vaccine for koi herpes virus (khv) disease
10/25/2007WO2007119248A1 A novel crystalline form of lamivudine
10/25/2007WO2007119006A1 New medicines for treatments against retroviruses
10/25/2007WO2007118987A1 Concentrate of chikungunya-specific immunoglobulins as medicine
10/25/2007WO2007118986A2 Concentrate of immunoglobulins and f(ab)'2 and/or fab fragments specific of an arbovirus as medicine
10/25/2007WO2007118979A1 Type 5 and type 8 capsular polysaccharides of superproducing staphylococcus aureus strains
10/25/2007WO2007118431A1 Use of trap protein as active ingredient for manufacturing a medicament for the treatment of staphylococcus aureus infection
10/25/2007WO2007118329A1 Methods and agents for treating tuberculosis
10/25/2007WO2007098591A3 Topical nail formulation
10/25/2007WO2007098270A3 Co-crystals comprising vx-950 and pharmaceutical compositions comprising the same
10/25/2007WO2007089903A3 Cationic steroid microbial compositions for treating or preventing influenza infections
10/25/2007WO2007056153B1 Peptide-dicer substrate rna conjugates as delivery vehicles for sirna
10/25/2007WO2002048116A3 Inhibitors of hepatitis c virus ns3 protease
10/25/2007US20070249813 recombinant human antibodies containing CDR3 domain having an amino acid sequence with alanine substitutions that specifically bind to human tumor necrosis factor alpha (hTNF alpha ) to treat autoimmune disorders ( rheumatic arthritis, allergy, multiple sclerosis, autoimmune diabetes)
10/25/2007US20070249692 Inhibitors of crystallization in a solid dispersion
10/25/2007US20070249655 4-Substituted-1,5-Dihydro-Pyrido[3,2-B]Indol-2-Ones
10/25/2007US20070249650 isolating and purifying quaternary ammonium alkaloid species from medicinal plant of Yan Huang Lian (Corydalis saxicola Bounting) through solvent extraction, crystallization and recrystallization; for treating viral hepatitis, hepatic injury, influenza, AIDS, tumors or arrhythmia
10/25/2007US20070249643 Solid pharmaceutical dosage form
10/25/2007US20070249637 Inhibitors Of Hepatitis C Virus Protease, And Compositions And Treatments Using The Same
10/25/2007US20070249630 Phenethanolamine derivatives for treatment of respiratory diseases
10/25/2007US20070249617 3-(6-p-Tolyl-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane; treatment of psychotic disorders such as schizophrenia, mania, depression and anxiety; neurodegenerataive disorders such as senile dementia, Alzhelmer's disease and other intellectual impairment disorders
10/25/2007US20070249601 Compounds and therapeutical use thereof
10/25/2007US20070249564 Novel phosphorus-containing prodrugs
10/25/2007US20070249524 High affinity ligands bind to clostridium difficile toxin A
10/25/2007US20070249021 Deglycosylated and Desialidated Long Pentraxin Ptx3
10/25/2007US20070249020 Cytokine zcytor17 ligand polypeptides and polynucleotides
10/25/2007US20070248706 Compositions and Methods for Activating Toll-like Receptor 4
10/25/2007US20070248704 Herbal extracts of salicornia species, process of preparation thereof, use thereof against tuberculosis
10/25/2007US20070248703 Topical Phytotherapeutic Compound for the Treatment of Herpes Based on Uncaria Tomentosa and Extraction Process for Obtaining a Vegetal Extract from Uncaria Tomentosa
10/25/2007US20070248700 Extractions and Methods Comprising Elder Species
10/25/2007US20070248680 Particles for Inactivating Toxins
10/25/2007US20070248679 Vaccine
10/25/2007US20070248626 Recombinant toxin fragments
10/25/2007US20070248624 (1,10B-Dihydro-2-(Aminocarbonyl-Phenyl)-5h-Pyrazolo[1,5-C][1,3]Benzoxazin-5-Yl)Phenyl Methanone Derivatives as Hiv Viral Replication Inhibitors
10/25/2007US20070248623 Gene Construction, Vector and Dna Vaccine for the Vaccination of Aquatic Animals
10/25/2007US20070248620 Method of treating malignancies and viral infections and improving immune function with a dietary supplement
10/25/2007US20070248617 Medical Uses of Carrier Conjugates of Non-Human Tnf -Peptides
10/25/2007US20070248616 Canine Respiratory Coronavirus (Crcv) Spike Protein, Polymerase and Hemagglutinin/Esterase
10/25/2007US20070248614 Vaccination
10/25/2007US20070248613 Human Antibodies Interacting with Hiv Gp41
10/25/2007US20070248601 Non-Human Transgenic Mammal for the Constant Region of the Class a Human Immunoglobulin Heavy Chain and Applications Thereof
10/25/2007US20070248598 Recombinant anti-VLA4 antibody molecules
10/25/2007US20070248589 Spatial for Altering Cell Proliferation
10/25/2007US20070248584 Immunomodulating Compositions, Uses Therefore and Processes for Their Production
10/25/2007US20070248582 Lactic Bacteria and Their Use in the Prevention of Diarrhea
10/25/2007US20070248573 Chimeric Bacteriophages, Chimeric Phage-Like Particles, and Chimeric Phage Ghost Particles, Methods for Their Production and Use
10/25/2007US20070248572 Method for treating diseases with omega interferon
10/25/2007CA2649796A1 A novel crystalline form of lamivudine
10/25/2007CA2649768A1 Use of trap protein per se as an active ingredient for the manufacture of a medicament for the treatment of staphylococcus aureus infection
10/25/2007CA2649290A1 Allogeneic cell therapy for treatment of opportunistic infection
10/25/2007CA2648678A1 Hcv inhibitors
10/25/2007CA2648298A1 Organic compounds and their uses
10/25/2007CA2647506A1 Concentrate of chikungunya-specific immunoglobulins as medicine
10/25/2007CA2647504A1 Concentrate of immunoglobulins and f(ab)'2 and/or fab fragments specific of an arbovirus as medicine
10/25/2007CA2645761A1 Antiviral methods
10/25/2007CA2645365A1 Type 5 and type 8 capsular polysaccharides of superproducing staphylococcus aureus strains
10/25/2007CA2640687A1 Anti-arenaviral compounds
10/24/2007EP1847602A1 STABILIZED HUMAN IgG1 AND IgG3 ANTIBODIES
10/24/2007EP1847593A1 Method for the purification, recovery, and sporulation of cysts and oocysts
10/24/2007EP1847550A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/24/2007EP1847549A2 Papillomavirus polyprotein constructs
10/24/2007EP1847263A2 Inhibitors against the production and release of inflammatory cytokines
10/24/2007EP1846439A2 Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants
10/24/2007EP1846430A1 New macrolides
10/24/2007EP1846418A2 Antibacterial agents
10/24/2007EP1846417A1 Antibacterial agents
10/24/2007EP1846416A2 Antibacterial agents
10/24/2007EP1846084A1 Device and method for treatment of wounds with nitric oxide
10/24/2007EP1846027A2 Improved vaccine against feline calicivirus
10/24/2007EP1846014A2 Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally senstive transmembrane peptide
10/24/2007EP1845995A1 Antibacterial agents
10/24/2007EP1845985A2 Amine derivative containing compositions and methods for the treatment of viral infections related to the etiology of cancer
10/24/2007EP1845964A1 Antimicrobial compositions comprising a natural agent selected from gallic acid, eucalyptol, naringin, a jasmonic acid compound and any combination thereof
10/24/2007EP1845785A1 Herbal composition for tinea infection
10/24/2007EP1581535B1 Pyrrolopyridazine derivatives
10/24/2007EP1505980B1 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission
10/24/2007EP1312366B1 Gelling aqueous pharmaceutical compositions
10/24/2007EP1311281B1 Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
10/24/2007EP1233982B1 Novel hcv non-structural polypeptide
10/24/2007EP1207860B1 Controlled release pellet formulation
10/24/2007EP1178983B1 Indole-type derivatives as inhibitors of p38 kinase
10/24/2007EP1156797B1 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
10/24/2007EP1112743B1 Nitrogenous heterocyclic carboxamide derivatives or salt thereof as antiviral agents
10/24/2007CN101061109A Novel pyridonecarboxylic acid derivatives or salts thereof
10/24/2007CN101060858A Method for determining dosage of oral inactivation vaccine
10/24/2007CN101060846A Compositions for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitors useful for injection
10/24/2007CN101060844A Combinations of a pyrimidine containing nnrti with rt inhibitors
10/24/2007CN101058832A Method for detecting growth hormone variations in humans, the variations and their uses
10/24/2007CN101058610A Codonopsisbulleyana polysaccharide sulfate and use thereof
10/24/2007CN101058602A Rana grahami boulenger antibiotic peptide, preparation method and application thereof
10/24/2007CN101058601A Horseshoe crab anti-endotoxin factor analogue peptide molecule, synthetic method and use thereof
10/24/2007CN101058575A Method of extracting and refining palmatin hydrochloride and application thereof
10/24/2007CN101058535A Di(7-hydrxyl-2,3-dihydro-1-1H-indeno)ether and the like, synthetic method and application
10/24/2007CN101057975A Cocktail vaccine for anti immune tolerance and immunodeficiency virus and its application
10/24/2007CN101057974A Simulated virus type rotavirus gene vaccine and its preparation method
10/24/2007CN101057971A Medicine for controlling livestock-poultry virus infectious disease
10/24/2007CN101057953A Multi-target cooperative control preparation for treating virus infectious disease
10/24/2007CN101057943A Medicine for treating dog parvovirus disease
10/24/2007CN101057918A Medicine for treating dog infectious hepatitis
10/24/2007CN101057912A Medicine for treating hepatitis and cirrhosis ascites and its preparation method
1 ... 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 ... 1798